Given the inflammation and hypercortisolism observed in depressed patients [44, 45], it is important to evaluate the impairment of the GR inhibitory function on NFκB, a neurobiological mechanism for the depressive disorder [1]. This evidence concerns the gene NFKB1 and adrenal gland hyperfunction.